Clinical trial
The AIM Study: Assessing the Impact of Margin Reduction
NCT00754000 is registered in ClinicalTrials.gov with Varian, a Siemens Healthineers Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The AIM Study: Assessing the Impact of Margin Reduction
- Lead sponsor
- Varian, a Siemens Healthineers Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- September 30, 2009
- Enrollment
- 82 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer